Rule 8.3 - INVERNESS MEDICAL INNOVATIONS INC

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing BARCLAYS PLC (Note 1) Company dealt in INVERNESS MEDICAL INNOVATIONS INC Class of relevant security COM STK USD0.001 to which the dealings being disclosed relate (Note 2) Date of dealing 10 August 2009 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant 2,205,464 2.74% 136,183 0.17% securities (2) Derivatives 0 0.00% (other than options) (3) Options and 129,800 0.16% 155,200 0.19% agreements to purchase/sell Total 2,335,264 2.90% 291,383 0.36% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of Long Short relevant security: Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of Securities Price per unit (GBP) Purchase 400 33.6525 Purchase 100 33.61 Purchase 50,000 33.6118 Purchase 200 33.595 Purchase 200 33.635 Purchase 100 33.55 Purchase 100 33.6 Purchase 100 33.62 Purchase 100 33.64 Purchase 1,700 33.62823529 Purchase 500 33.43 Purchase 100 33.63 Purchase 100 33.39 Purchase 400 33.6175 Purchase 1,300 33.63 Purchase 100 33.68 Purchase 300 33.55666667 Purchase 100 33.641 Purchase 44 33.5800 USD Purchase 100 33.641 Purchase 500 33.43 Purchase 2,100 33.61333333 Purchase 110 33.5800 USD Purchase 600 33.615 Purchase 20 33.61 Purchase 100 33.61 Purchase 150 33.58 Purchase 950 33.65736842 Sale 340 33.5800 USD Sale 726 33.5800 USD Sale 100 33.6800 USD Sale 1,844 33.68240781 Sale 600 33.68 Sale 5,000 33.6261 Sale 200 33.675 Sale 100 33.6 Sale 100 33.641 Sale 100 33.641 Sale 200 33.535 Sale 100 33.68 Sale 100 33.61 Sale 1,400 33.6264 Sale 500 33.43 Sale 1,200 33.65166667 Sale 510 33.32179412 Sale 900 33.67555556 Sale 1,800 33.62444444 Sale 200 33.555 Sale 276 33.75304348 Sale 500 33.43 Sale 100 33.64 Sale 16 33.5800 USD Sale 1,300 33.63 Sale 44,356 33.60438272 Sale 1,000 33.69 Sale 100 33.39 (b) Derivatives transactions (other than options) Product name, Long/Short Number of Price per (e.g. CFD) (Note 6) Securities unit (GBP) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, e.g. Expiry Option money e.g. call selling, securities to price American, date paid/received option purchasing, which the option European etc. per unit (GBP) varying etc. relates (GBP) (ii) Exercising Product name, e.g. Number of Exercise price per call option securities unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION None Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) YES Date of disclosure 11 August 2009 Contact name Geoff Smith Telephone number 020 7116 2913 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) Product name, Written or Number of securities Exercise price Type, e.g. Expiry date e.g. call option purchased to which the option (Note 2) American, or derivative relates European etc. Option Purchased -3,000 35.0000 AMER 20/02/2010 Option Purchased -100 17.5000 AMER 22/08/2009 Option Purchased -200 35.0000 AMER 21/11/2009 Option Purchased -200 25.0000 AMER 20/02/2010 Option Purchased -400 35.0000 AMER 22/01/2011 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased -700 40.0000 AMER 16/01/2010 Option Purchased -1,400 30.0000 AMER 22/01/2011 Option Purchased -2,000 22.5000 AMER 22/08/2009 Option Purchased -2,100 25.0000 AMER 22/01/2011 Option Purchased -2,300 35.0000 AMER 22/08/2009 Option Purchased -40,000 40.0000 AMER 22/08/2009 Option Purchased -2,900 55.0000 AMER 22/01/2011 Option Purchased -100 25.0000 AMER 21/11/2009 Option Purchased -3,000 30.0000 AMER 21/11/2009 Option Purchased -4,300 50.0000 AMER 22/01/2011 Option Purchased -4,400 55.0000 AMER 16/01/2010 Option Purchased -4,600 25.0000 AMER 16/01/2010 Option Purchased -4,700 40.0000 AMER 21/11/2009 Option Purchased -5,200 35.0000 AMER 16/01/2010 Option Purchased -9,100 35.0000 AMER 19/09/2009 Option Purchased -10,500 30.0000 AMER 22/08/2009 Option Purchased -10,900 30.0000 AMER 22/08/2009 Option Purchased -16,000 40.0000 AMER 19/09/2009 Option Purchased -23,600 25.0000 AMER 22/08/2009 Option Purchased -2,800 25.0000 AMER 16/01/2010 Option Purchased 600 35.0000 AMER 21/11/2009 Option Purchased 7,500 35.0000 AMER 22/08/2009 Option Purchased 6,900 30.0000 AMER 16/01/2010 Option Purchased 4,700 20.0000 AMER 16/01/2010 Option Purchased 4,200 30.0000 AMER 16/01/2010 Option Purchased 2,700 45.0000 AMER 21/11/2009 Option Purchased 2,600 50.0000 AMER 16/01/2010 Option Purchased 2,500 45.0000 AMER 16/01/2010 Option Purchased 1,800 40.0000 AMER 22/01/2011 Option Purchased 1,600 30.0000 AMER 21/11/2009 Option Purchased 1,600 25.0000 AMER 19/09/2009 Option Purchased 1,100 40.0000 AMER 20/02/2010 Option Purchased -100 17.5000 AMER 16/01/2010 Option Purchased 900 35.0000 AMER 16/01/2010 Option Purchased -100 22.5000 AMER 22/01/2011 Option Purchased 600 22.5000 AMER 22/08/2009 Option Purchased 400 50.0000 AMER 21/11/2009 Option Purchased 300 40.0000 AMER 21/11/2009 Option Purchased 200 15.0000 AMER 22/01/2011 Option Purchased 100 35.0000 AMER 20/02/2010 Option Purchased 100 22.5000 AMER 22/01/2011 Option Purchased 100 20.0000 AMER 16/01/2010 Option Purchased 100 17.5000 AMER 22/01/2011 Option Purchased 100 15.0000 AMER 16/01/2010 Option Purchased 100 12.5000 AMER 22/01/2011 Option Purchased 87,900 35.0000 AMER 22/08/2009 Option Purchased 1,100 20.0000 AMER 22/08/2009 Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

Companies

Barclays (BARC)
UK 100

Latest directors dealings